When was Gentium founded?

Gentium was founded in 1993 and raised its 1st funding round 11 years after it was founded.

Where is Gentium located?

Gentium is headquartered in Villa Guardia, Italy.

Is Gentium a funded company?

Gentium is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Oct 2004.

When was the latest funding round of Gentium?

Gentium's latest funding was a $***** Post IPO round on Feb 07, 2007, with participation from 0 investor. Its primary sector is Traditional Pharmaceuticals. In Italy, the Traditional Pharmaceuticals sector has seen $493M in funding in 2026 to date.

Where does Gentium rank among its competitors?

Gentium ranks 499th amongst 1239 active competitors, of which 43 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Gentium?

Gentium's top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Gentium - 2026 Company Profile, Team, Funding & Competitors

Gentium is an acquired company based in Villa Guardia (Italy), founded in 1993. It operates as a Manufacturer of fish processing machinery and spare parts. Gentium has raised an undisclosed amount in funding. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.

Company Details

Manufacturer of fish processing machinery and spare parts. This company designs and manufactures equipment for filleting, heading, skinning, and scaling fish. The machinery is adaptable to various fish species. A comprehensive inventory of spare parts ensures prompt maintenance and repair. The company also provides ongoing service support.

Website: gentium.com
Email ID: *****@gentium.it
Phone Number: +39 **********

Key Metrics

Founded Year

1993

Location

Villa Guardia, Italy

Stage

Acquired

Latest Funding Round

Post IPO, Feb 07, 2007, $*****

Investors

Valence Life Sciences & 1 more

Ranked

499^th among 1239 active competitors

Similar Companies

Teva Pharmaceuticals & 1463 more

Exit Details

Acquired by Jazz Pharmaceuticals (Dec 19, 2013)

View Gentium's full profile

Gentium got acquired by Jazz Pharmaceuticals on Dec 19, 2013 at an acquisition amount of $*****.

Click here to take a look at Gentium's acquisition in detail

Gentium has raised funding over 3 rounds. Its first funding round was on Oct 2004. Gentium has 2 institutional investors.

Here is the list of recent funding rounds of Gentium:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 07, 2007	4979171	Post IPO	1924981	8144772	1313537	5495132
May 2006	9594556	Post IPO	1084753	2714805	3247306	4328937
Oct 2004	7625544	Post IPO	2255140	4071685	8398606	8956728

Access funding benchmarks and valuations. Sign up today!

View details of Gentium's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Gentium include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of Gentium, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100
499th	Gentium 1993, Villa Guardia (Italy), Acquired	Manufacturer of fish processing machinery and spare parts	-	Valence Life Sciences, Great Point Partners	33/100